SRINAGAR: The Department of India System of Medicine that is also part of the frontline workers against the scourge of Covid-19 has reached nearly 1.10 lakh individuals with free immunity boosters. The operation of reaching the vulnerable, aged and especially the frontline workers will continue until the battle against the Covid-19 is won.

Dr Iftikhar H Gazi

“Primarily, we are reaching the frontline workers against the pandemic,” Dr Iftikhar Hussain Gazi, the Divisional Nodal Officer of ISM for the counter pandemic efforts said. “Apart from thousands of health workers, the immunity boosters were supplied to the police and officials of various departments who are working in these harsh conditions. These include municipal and other workers also.”

Gazi said ISM’s 450 medical officers and more than 250 pharmacists are working with the directorate of health services on the ground these days. “Our people are busy on all fronts including contact tracing, sample collection and on the ground zero in dispensaries as well,” he said. “A number of our people are deployed in the quarantine centre also for the last three months.”

This is the basic immune boosting pack that ISM is providing the front-line workers. KL Image: Bilal Bahadur

The immunity-boosting medicine is a pack of five different medicines including Aanab (Jujube fruit), Ashwagandha, Darchini Cinnamon), Sepestan and other things. These items are part of the all-India efforts by the Ministry of Ayush to help improve the immunity of the vulnerable and those deployed in counter pandemic efforts. This pack of medicine is for a fortnight and is also available with the dispensaries and offices of the ISM across Jammu and Kashmir. The department said that in the case of the health workers and the vulnerable, they will be supplying the second pack once the first is consumed.

Dr Gazi said the people who are vulnerable to Covid-19 infection are those with cardiac issues, cancer and sugar problems. Mostly the aged are vulnerable and high-risk individuals because of co-morbidity issue, he added.

LEAVE A REPLY

Please enter your comment!
Please enter your name here